![Kathleen Wilkinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Wilkinson
Personalreferent bei
RAPPORT THERAPEUTICS, INC.
Profil
Kathleen Wilkinson is currently the Director at North Texas Commission and the Chief People Officer at Rapport Therapeutics, Inc. Formerly, Ms. Wilkinson was the Chief People Officer at 2seventy Bio, Inc. from 2022 to 2024, the Chief People Officer at bluebird bio, Inc. in 2021, and the Operations Director at Adnexus.
Ms. Wilkinson completed undergraduate studies at Harvard University.
Aktive Positionen von Kathleen Wilkinson
| Unternehmen | Position | Beginn |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Personalreferent | 01.02.2024 |
North Texas Commission
 North Texas Commission Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit membership-supported organization | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kathleen Wilkinson
| Unternehmen | Position | Ende |
|---|---|---|
| 2SEVENTY BIO, INC. | Personalreferent | 01.02.2024 |
| GENETIX BIOTHERAPEUTICS, INC. | Personalreferent | 01.12.2021 |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Geschäftsführer | - |
Ausbildung von Kathleen Wilkinson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
North Texas Commission
North Texas Commission Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit membership-supported organization | Commercial Services |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
